6550--Loflupane - Brand Name or Equal
ID: 36C24425Q0226Type: Combined Synopsis/Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF244-NETWORK CONTRACT OFFICE 4 (36C244)PITTSBURGH, PA, 15215, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)
Timeline
    Description

    The Department of Veterans Affairs, Network Contracting Office 4, is seeking proposals for a firm-fixed price contract to supply Radiopharmaceutical Isotopes, specifically I-123 Ioflupane (brand name DaTscan), for the Nuclear Medicine Department at the Philadelphia VA Medical Center. This contract will cover one base year with four option years, requiring daily supplies for diagnostic imaging procedures, including emergency deliveries, and mandates compliance with regulations from the Nuclear Regulatory Commission and the FDA. The goods are critical for providing reliable and efficient healthcare solutions for veterans, and proposals must be submitted by January 10, 2025. Interested vendors should direct any questions to Contracting Officer Amanda Saunders at amanda.saunders@va.gov.

    Point(s) of Contact
    Amanda SaundersContracting Officer
    (412) 503-3555
    amanda.saunders@va.gov
    Files
    Title
    Posted
    The Department of Veterans Affairs, Network Contracting Office 4, is soliciting proposals for a firm-fixed price contract to supply Radiopharmaceutical Isotopes, specifically I-123 Ioflupane (brand name DaTscan), for the Nuclear Medicine Department at the Philadelphia VA Medical Center. The contract encompasses one base year with four options, requiring daily supplies for diagnostic imaging procedures, including emergency deliveries. Vendors must provide unit doses with detailed labeling, including preparation and expiration information. Compliance with various regulations, such as those from the Nuclear Regulatory Commission and the FDA, is mandated. The solicitation indicates a need for electronic tracking and proper return protocols for unused products. Proposals must be submitted by January 10, 2025, with questions directed to the contracting officer, Amanda Saunders. The contract's evaluation will consider technical capability, past performance, and pricing, reflecting the government's pursuit of reliable and efficient healthcare solutions for veterans.
    Lifecycle
    Title
    Type
    Combined Synopsis/Solicitation
    Similar Opportunities
    6505--Radiopharmaceuticals (STX)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the provision of radiopharmaceuticals for the South Texas Veterans Health Care System located in San Antonio, Texas. The selected contractor will be responsible for supplying both low and high energy radiopharmaceuticals essential for diagnosis and treatment in Nuclear Medicine Imaging, with a delivery period from January 11, 2025, to January 10, 2028. This procurement is critical for ensuring timely and effective healthcare services for veterans, adhering to stringent regulatory standards, and maintaining a consistent supply of necessary medical products. Interested offerors must submit their proposals by January 7, 2025, to Contract Specialist Vance Farrell at vance.farrell@va.gov, with a guaranteed minimum contract value of $10,000.
    Radiation Oncology Physician Services
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to provide Radiation Oncology Physician Services at the Dayton VA Medical Center, under solicitation number 36C25024Q03461. The contract will span from January 15, 2025, to January 14, 2030, and includes five 12-month ordering periods, requiring board-certified physicians to deliver both routine and emergency on-call services while adhering to established medical guidelines and credentialing standards. This procurement is vital for ensuring high-quality care for veterans, emphasizing the importance of compliance with federal regulations and performance expectations. Interested bidders should contact Jennifer Bowden at jennifer.bowden@va.gov or call 937-268-6511 X3041 for further details and to obtain the necessary documentation.
    6505--Carbidopa/Levodopa SA Tablet
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) 36E79725R0008 for the procurement of Carbidopa/Levodopa sustained release (SA) tablets, aimed at ensuring a continuous supply of these medications for various federal health services, including the Department of Defense and the Bureau of Prisons. The contract will be awarded for an initial period of one year, with the option to extend for four additional one-year periods, requiring offerors to provide unique branding and packaging without overlapping labels. The estimated annual usage totals approximately 119,875 bottles across two dosage forms, highlighting the importance of these medications in treating Parkinson's disease and related conditions. Interested parties should note that the electronic solicitation is expected to be issued around January 3, 2026, with offers due by January 17, 2026; questions can be directed to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov.
    6505--Tamsulosin Capsules
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    6505--Nadolol Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0014 concerning the procurement of Nadolol Tablets. This procurement aims to secure an uninterrupted supply of Nadolol Tablets for various federal health entities, including the VA, Department of Defense (DoD), Bureau of Prisons, and Indian Health Service, with a contract period of one year and four optional one-year extensions. The estimated annual requirements include approximately 7,753 bottles of 20MG, 6,085 bottles of 40MG, and 1,566 bottles of 80MG tablets, all of which must feature unique labeling (NDC number) as specified. The solicitation is expected to be released electronically on or around January 10, 2025, with responses due by January 27, 2025. Interested suppliers can direct inquiries to Contract Specialist Richard Mahario at Richard.Mahario@va.gov.
    6505--Baclofen Tablets (VA-25-00026620)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0015 for the procurement of Baclofen Tablets, aimed at ensuring a reliable supply for various federal health facilities, including the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The procurement will cover a one-year contract with four additional pre-priced option years, requiring offerors to provide products labeled with their unique National Drug Code (NDC) numbers. This initiative is critical for maintaining uninterrupted access to essential medications for veterans and other federal health service users. Interested suppliers should note that the solicitation will be electronically posted on or around December 30, 2024, with a submission deadline of January 13, 2025; inquiries can be directed to Contract Specialist Adrienne A. Albachiara at adrienne.albachiara@va.gov.
    6505--Abiraterone Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Abiraterone Acetate Tablets through its Pharmaceutical Prime Vendor Program. Offerors are required to comply with the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP), providing a unique 11-digit National Drug Code (NDC) for each drug, along with pricing for the base year and four optional years, including a Cost Recovery Fee. This procurement is crucial for ensuring consistent availability and competitive pricing of essential medications for federal healthcare users, particularly veterans. Interested parties must submit their proposals by the extended deadline of January 8, 2025, at 2:30 PM CST, and can contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further information.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Metformin IR Tablets - REPACK PROGRAM
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Metformin HCL IR Tablets under solicitation number 36E79725R0013. This procurement aims to ensure a consistent supply of Metformin for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center, with a contract term of one year and four optional annual extensions. The successful bidders must provide unique drug labeling with a distinct National Drug Code (NDC), as the packaging must exclusively display the contractor's label without overlapping with others. The solicitation is expected to be released electronically on January 21, 2025, with a submission deadline of February 4, 2025. Interested parties can direct inquiries to Contracting Officer Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852.
    Preventative Maintenance and Service Package for the Mediso nanoScan PET/CT animal imager
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking qualified vendors to provide a Preventative Maintenance and Service Package for the Mediso NanoScan PET/CT animal imager. This procurement involves a comprehensive service plan that includes a 12-month base period followed by four optional 12-month periods, commencing on February 10, 2025, at the Biomedical Research Center in Baltimore, Maryland. The Mediso NanoScan PET/CT is crucial for advanced imaging in biomedical research, and the selected vendor must demonstrate technical capabilities, customer support, and delivery speed as part of the evaluation process. Interested parties should note that the Request for Quotation (RFQ) number is 75N95025Q00104, with responses due by January 6, 2025. For further inquiries, vendors can contact Andrew Varley at andrew.varley@nih.gov or Joshua T. Lazarus at Josh.Lazarus@nih.gov.